SP110 Nuclear Body Protein (SP110) (Middle Region) Peptide
-
- Target See all SP110 products
- SP110 (SP110 Nuclear Body Protein (SP110))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SP110 antibody (Catalog #: ARP36126_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SP110 (SP110 Nuclear Body Protein (SP110))
- Background
-
The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. SP110 is a member of the SP100/SP140 family of nuclear body proteins and is a leukocyte-specific nuclear body component. The protein can function as a
Alias Symbols: FLJ22835, IFI41, IFI75, VODI, IPR1
Protein Interaction Partner: NDUFV2,NDUFV2
Protein Size: 713 - Molecular Weight
- 81 kDa
- Gene ID
- 3431
- NCBI Accession
- NM_080424, NP_536349
-